Patents by Inventor Stephen Paul ARNS

Stephen Paul ARNS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230295075
    Abstract: Compounds are provided having the following structure: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R3, L1, L2, G1, G2 and G3 are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.
    Type: Application
    Filed: December 15, 2022
    Publication date: September 21, 2023
    Inventors: Xinyao Du, Steven M. Ansell, Jason Samuel Tan, Polina Blagojevic, Stephen Paul Arns, Julia Gatenyo
  • Publication number: 20220112242
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I: compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 14, 2022
    Inventors: STEPHEN PAUL ARNS, JAMES BRIAN JAQUITH, DAVY JEREMY BAUDELET, ERIC ROY SIMONSON, RICHARD TOM LIGGINS, NAG SHARWAN KUMAR, TOM HAN HSIAO HSIEH
  • Patent number: 11279732
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: March 22, 2022
    Assignee: CDRD VENTURES INC.
    Inventors: Stephen Paul Arns, James Brian Jaquith, Davy Jérémy Baudelet, Eric Roy Simonson, Richard Tom Liggins, Nag Sharwan Kumar, Tom Han Hsiao Hsieh
  • Publication number: 20190040102
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Application
    Filed: February 9, 2017
    Publication date: February 7, 2019
    Inventors: Stephen Paul ARNS, James Brian JAQUITH, Davy Jérémy BAUDELET, Eric Roy SIMONSON, Richard Tom LIGGINS, Nag Sharwan KUMAR, Tom Han Hsiao HSIEH